Op Maandag 22 November 15:00-16:30 CET (online, Engels). Registeer je hier.
Veel oude/nieuwe medicijnen zijn ontoegankelijk of zijn excessief hoog geprijsd. Welke wetten geven farmaceutische bedrijven de ruimte om zo te opereren? En welke juridische mechanismen kunnen gebruikt worden om een einde te maken aan deze onrechtvaardige handelswijzen?
Stichting Farma ter Verantwoording (FtV) is een richtlijn voor NGOs aan het opstellen over het gebruik van juridische procedures ter bevordering van de toegang tot medicijnen. Zo willen we bijdragen aan het beëindigen van onrechtvaardige handelswijzen van farmaceuten, zoals we in ook in deze Covid-19 tijden zien.
Tijdens de webinar zullen een aantal voorbeelden uit het verleden aan bod komen waar we lessen uit kunnen trekken, omdat ze (on)succesvol toegepast zijn om bijv. toegang tot medicijnen te bereiken of excessieve prijzen aan te vechten.
Activisten of NGOs die betrokken waren bij zulke zaken zullen hun ervaringen delen.
De volgende deelnemers zullen plaatsnemen in het panel:
- Mark Heywood, on “How civil society got access to ARVs (antiretrovirals) during the HIV/AIDS crisis in South Africa”
- Ellen ’t Hoen (Medicines Law & Policy) on “Use of Compulsory Licenses and the role of civil society”
- Sergey Golovin (Intl Treatment Preparedness Coalition, Rusland) on “The remdesivir Compulsory License in Russia”
- Felipe Carvalho (Artsen Zonder Grenzen Brazilië) on “Using the law to promote access to HIV/AIDS medicines and Covid-19 vaccines in Brazil”
- Nele Meyer (Legal Advisor, Business and Human Rights, Amnesty International) on the recent Amnesty report “A Double Dose of Inequality: Pharma companies and the Covid-19 vaccines crisis” and recent EU ‘due diligence’ legislation to promote businesses’ respect for human rights.
Na het delen van hun verhalen zullen de paneldeelnemers bediscussiëren hoe de geleerde lessen te implementeren zullen zijn in FTV’s Juridische Richtlijnen voor NGOs (Legal Guidelines for NGOs)
Registreer je voor het evenement via dit formulier.
We zullen de zoom link mailen in de week voor het evenement naar de aangemelde deelnemers. Het evenement wordt opgenomen. Dit eventement vindt plaats in het Engels.
Mark Heywood
Mark Heywood is a South African human rights and social justice activist based in Johannesburg. He studied English language and literature at Oxford University and later African literature at the University of the Witwatersrand. He was head of the AIDS Law Project (1997-2010) and Executive Director of SECTION27 (2010-2019). He also co-founded the Treatment Action Campaign (TAC), the AIDS and Rights Alliance of Southern Africa (ARASA), Corruption Watch and Save South Africa.
He has published extensively on HIV, human rights, the law and politics in both academic and popular media, including co-editing the “AIDS and the Law Resource Manual and Health & Democracy: A guide to human rights, health law and policy in post-Apartheid South Africa”. Mark has chronicled his personal journeys towards social justice in his recent book Get Up! Stand Up! (Tafelberg, 2017).
Ellen F. M. ‘t Hoen LLM PhD
Ellen ‘t Hoen (1960) is the director of Medicines Law & Policy, a group of legal and policy experts offering advice to international organizations and governments. From 1999 until 2009 she was the director of policy for Médecins sans Frontières. In 2009 she joined UNITAID in Geneva to set up the Medicines Patent Pool (MPP). She was the MPP’s first executive director until 2012.
She has published widely and is the author of several books. In 2017 she received the Prix Prescrire for her book “Private Patents and Public Health: Changing intellectual property rules for public health.”. In 2005, 2006, 2010, 2011 and in 2020 she was listed as one of the 50 most influential people in intellectual property by the journal Managing Intellectual Property. In 2020, she was appointed Officer of the Order of Oranje-Nassau, a royal award given in recognition of her work on access to medicines.
She has a master’s degree in law from the University of Amsterdam and a PhD from the University of Groningen where she remains a Global Health Law Fellow at the law faculty.
Sergey Golovin
Sergey Golovin has worked in the field of healthcare and treatment access for around 10 years, specializing in monitoring availability and prices of essential medicines and linking IP issues with the treatment access agenda.
Currently, Sergey is employed as Intellectual Property and Access Lead at the Treatment Preparedness Coalition in Eastern Europe and Central Asia, supervising a variety of research and advocacy projects with a focus on ways to improve treatment access using the resources of community organizations.
Felipe de Carvalho MA
Felipe de Carvalho is a journalist, with a Master’s degree in International Political Economy at the Federal University of Rio de Janeiro (UFRJ). Felipe works at MSF since 2009, with a special focus on access to medicines, diagnostics and vaccines; intellectual property law; Research and Development (R&D) principles and policies; global health and multilateral cooperation. Currently, Felipe is engaged with MSF Access Campaign efforts to ensure availability and accessibility of health tools to address the Covid-19 pandemic. Felipe is also a Civil Society representative at the Access to COVID-19 Tools (ACT) Accelerator, in the treatment pillar.
Nele Meyer
Nele Meyer is Legal Advisor, Business and Human Rights, at the Amnesty International European Institutions Office in Brussels.